MCRB Matthew R. Henn sold Seres Therapeutics, Inc. shares — SEC Form 4SELLSeres Therapeutics, Inc.

Matthew R. Henn, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 77 shares at $7.53 ($580) on 2026-05-18, disclosed to the SEC on 2026-05-19.

SEC EDGAR Filing

0001193125-26-230727

View on SEC EDGAR

Trade context

Scheduled sale ($580) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Weak47/100

Negative factors outweigh the positive ones.

Opportunistic SellExercise & Sell

Filing Info

Filed2026-05-19

Traded2026-05-18

Accession0001193125-26-230727

SourceSEC EDGAR (Live)

Insider

NameMatthew R. Henn

TitleSee Remarks

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
MCRB	SELL	2026-08-18	$369	—	Filing →
MCRB	SELL	2026-02-18	$754	—

Get alerted the next time MCRB files

Every new MCRB Form 4, within minutes of it hitting EDGAR. 7-day free trial, no credit card required.

Follow MCRB

MCRB Matthew R. Henn sold Seres Therapeutics, Inc. shares — SEC Form 4SELLSeres Therapeutics, Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes